ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag tuberculosis clinical trials drug development industry

Tuberculosis Trial Launched
Hannah Waters | Mar 20, 2012 | 1 min read
The TB Alliance will test a new combination of drugs to combat normal and multi-drug-resistant tuberculosis.
New Drug Combo for ALS Slows Decline in Small Clinical Study
Jef Akst | Sep 3, 2020 | 3 min read
After six months, patients with fast-progressing amyotrophic lateral sclerosis who had received the experimental treatment had less loss of function than those who received a placebo.
New clinical trials initiative steps closer
Robert Walgate(walgate@scienceanalysed.com) | Sep 8, 2002 | 3 min read
EU and Africa plan co-operation on drug development
Accelerating new drug development
John Borchardt(JKBdeinker@aol.com) | Jan 29, 2001 | 4 min read
US FDA user fees may have accelerated new drug development but a recent survey suggests difficulties in obtaining volunteers for human clinical trials still slow progress.
CRISPR to Debut in Clinical Trials
Diana Kwon | Dec 13, 2017 | 2 min read
The first industry-sponsored CRISPR therapy is slated to be tested in humans in 2018.
Lazarus Drugs
Kate Yandell | Feb 1, 2015 | 8 min read
While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.
 
A needle drawing up fluid from an unlabeled vial.
Cancer Vaccination as a Promising New Treatment Against Tumors
Shelby Bradford, PhD | Mar 15, 2024 | 10+ min read
Vaccination has beaten back infections for more than a century. Now, it may be the next big step in battling cancer.
How Vesselon Can Improve the Entire Class of Antibody-Drug Conjugates
Clayton Larsen - President & CEO, Vesselon, Inc. | Oct 30, 2023 | 4 min read
Vesselon’s novel co-formulation of gas lipid microspheres and self-assembling liposomes, targeted and activated by commercial ultrasound, would be an ideal adjunct to any of these ADC drugs.
Infusion of Artificial Intelligence in Biology
Meenakshi Prabhune, PhD | Feb 23, 2024 | 10 min read
With deep learning methods revolutionizing life sciences, researchers bet on de novo proteins and cell mapping models to deliver customized precision medicines.
The Tribulations of Clinical Trials
Susan Warner | Apr 25, 2004 | 10+ min read
PictureQuestA plain tablet in a no-name blisterpack. It could save a life.Or maybe not.Since 1994, the Food and Drug Administration has approved year-to-year increases in the number of new candidate drugs for human testing in the United States, rising from 3,350 in 1996 to 3,900 in 2002.1 But the number of drugs that successfully negotiate the trial process and ultimately receive FDA approval is frustratingly low. Despite pharmaceutical companies' and the National Institutes of Health's research

Run a Search

ADVERTISEMENT